Hugh Pelham discusses research collaboration between LMB and AstraZeneca in more depth

Mike Scialom talks to Sir Hugh Pelham about why pledge from the MRC LMB and AstraZeneca could mean good news for Cambridge. This article is no longer available from the source website: Cambridge News 20 May 2014